EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The role of autoantibodies in the neuropsychiatric manifestations of 22q11 deletion syndrome

Suzain Ali iD, Brad D Pearce iD

Acta Neuropsychiatrica · 2025

DOI: 10.1017/neu.2025.10046 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Neuropsychiatrica, 2025. Verfasst von Suzain Ali und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department Epidemiology, Rollins School of Public Health, https://ror.org/03czfpz43Emory University, Atlanta, GA, USA. Hauptthemen laut MEDLINE: Autoantibodies, DiGeorge Syndrome, 22q11 Deletion Syndrome. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The 22q11.2 deletion syndrome (22q11DS) is a genetic disorder characterised by defined microdeletions at chromosome 22q11.2. These genetic changes lead to a variety of neurodevelopmental problems, including cognitive delays and a very high rate of symptoms on the autism and schizophrenia spectrum. The underlying mechanisms contributing to these neurodevelopmental manifestations remain poorly understood. In concert with these neurodevelopmental difficulties there are also immune system alterations, including autoimmunity. We hypothesise that immune dysfunction and the presence of circulating autoantibodies may play a role in the pathophysiology of these neuropsychiatric symptoms. In this review, we synthesise the diverse literature on autoantibodies in 22q11DS and propose mechanisms for a causative role of these autoantibodies in neurobehavioural problems such as psychosis and cognitive delays. This review highlights the importance of further research to explore the interaction between autoreactive antibodies and functional alterations in neurocircuitry function. Understanding this relationship may provide insight into the origins of psychiatric symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutoantibodiesDiGeorge Syndrome22q11 Deletion SyndromeHumansPsychotic Disorders

Stichwörter der Autor:innen

22q11DSautoantibodiesautoimmunityneuropsychiatricschizophrenia

Substanzen

Autoantibodies

Autor:innen und Institutionen

  • Department Epidemiology, Rollins School of Public Health, https://ror.org/03czfpz43Emory University, Atlanta, GA, USA.

ORCID-Profile: Suzain Ali, Brad D Pearce

Förderung

  • NIMH NIH HHS

Zitieren

APA

Ali, S., & Pearce, B. D. (2025). The role of autoantibodies in the neuropsychiatric manifestations of 22q11 deletion syndrome. Acta Neuropsychiatrica. https://doi.org/10.1017/neu.2025.10046

Vancouver

Ali S, Pearce BD. The role of autoantibodies in the neuropsychiatric manifestations of 22q11 deletion syndrome. Acta Neuropsychiatrica. 2025. doi:10.1017/neu.2025.10046

BibTeX
@article{Ali2025,
  author = {Ali, Suzain and Pearce, Brad D},
  title = {The role of autoantibodies in the neuropsychiatric manifestations of 22q11 deletion syndrome},
  journal = {Acta Neuropsychiatrica},
  year = {2025},
  doi = {10.1017/neu.2025.10046}
}
Kostenlos starten →